Screening for Unhealthy Drug Use: US Preventive Services Task Force Recommendation Statement

JAMA : the Journal of the American Medical Association
US Preventive Services Task ForceJohn B Wong

Abstract

An estimated 12% of adults 18 years or older and 8% of adolescents aged 12 to 17 years report unhealthy use of prescription or illegal drugs in the US. To update its 2008 recommendation, the USPSTF commissioned reviews of the evidence on screening by asking questions about drug use and interventions for unhealthy drug use in adults and adolescents. This recommendation statement applies to adults 18 years or older, including pregnant and postpartum persons, and adolescents aged 12 to 17 years in primary care settings. This statement does not apply to adolescents or adults who have a currently diagnosed drug use disorder or are currently undergoing or have been referred for drug use treatment. This statement applies to settings and populations for which services for accurate diagnosis, effective treatment, and appropriate care can be offered or referred. In adults, the USPSTF concludes with moderate certainty that screening by asking questions about unhealthy drug use has moderate net benefit when services for accurate diagnosis of unhealthy drug use or drug use disorders, effective treatment, and appropriate care can be offered or referred. In adolescents, because of the lack of evidence, the USPSTF concludes that the benefits a...Continue Reading

References

Jun 1, 1981·Journal of Pharmaceutical Sciences·E A Julian, E M Plein
Jan 20, 2006·Journal of the American Geriatrics Society·Miriam RodinUNKNOWN Department of Veterans Affairs/Department of Defense
Mar 12, 2008·Annals of Family Medicine·UNKNOWN US Preventive Services Task Force
Dec 22, 2010·Obstetrics and Gynecology·UNKNOWN American College of Obstetricians and Gynecologists Committee on Health Care for Underserved Women
Feb 24, 2011·Obstetrics and Gynecology·UNKNOWN American College of Obstetricians and Gynecologists Committee on Health Care for Underserved Women
Nov 26, 2011·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·Michael HarringtonJames Bolton
Apr 13, 2013·Substance Abuse : Official Publication of the Association for Medical Education and Research in Substance Abuse·Hendrée E Jones
Aug 2, 2013·The New England Journal of Medicine·Christopher J L Murray, Alan D Lopez
May 21, 2014·Annals of Internal Medicine·Michael L LeFevre, UNKNOWN U.S. Preventive Services Task Force
Jul 15, 2015·Journal of the American Board of Family Medicine : JABFM·Jun LiIngrid J Hall
Sep 21, 2015·Current Psychiatry Reports·Ariadna Forray, Dawn Foster
Jan 28, 2016·JAMA : the Journal of the American Medical Association·Albert L SiuMichael P Pignone
Feb 10, 2016·Annals of Internal Medicine·Albert L Siu, UNKNOWN U.S. Preventive Services Task Force
Jun 22, 2016·Pediatrics·Sharon J L LevyUNKNOWN COMMITTEE ON SUBSTANCE USE AND PREVENTION
Jun 25, 2016·Child and Adolescent Psychiatric Clinics of North America·Aditi Sharma, Jonathan D Morrow
Sep 11, 2016·Child and Adolescent Psychiatric Clinics of North America·Christopher J Hammond
Oct 11, 2016·Journal of Child & Adolescent Substance Abuse·Jordan P DavisLeah Cleeland
Jul 26, 2017·Obstetrics and Gynecology·UNKNOWN Committee on Obstetric Practice
Sep 25, 2017·Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'obstétrique Et Gynécologie Du Canada : JOGC·Jocelynn L CookSuzanne Wong
Dec 22, 2017·Obstetrics and Gynecology·Alain Braillon, Susan Bewley
Aug 23, 2018·Obstetrics and Gynecology·Jessica McKinneyCarrie Pagliano
Nov 14, 2018·JAMA : the Journal of the American Medical Association·UNKNOWN US Preventive Services Task ForceJohn B Wong
Dec 24, 2018·Obstetrics and Gynecology·UNKNOWN American College of Obstetricians and Gynecologists, UNKNOWN Society for Maternal-Fetal Medicine
Dec 24, 2018·Obstetrics and Gynecology
Jan 4, 2019·MMWR. Morbidity and Mortality Weekly Report·Lawrence SchollGrant Baldwin

❮ Previous
Next ❯

Citations

Jul 17, 2020·MMWR. Morbidity and Mortality Weekly Report·Jean Y KoWanda D Barfield
Aug 14, 2020·MMWR. Morbidity and Mortality Weekly Report·Jean Y KoAlthea M Grant
Sep 17, 2020·Current Psychiatry Reports·Nancy ByattTiffany A Moore Simas
Feb 13, 2021·Pediatric Annals·Gregg Joseph MontaltoMaria H Rahmandar
Feb 26, 2021·Nature Reviews. Disease Primers·Jason P ConnorWayne D Hall
Mar 19, 2021·Addiction Science & Clinical Practice·Majid AfsharNiranjan S Karnik
Sep 11, 2020·Drug and Alcohol Dependence·Theresa E MatsonJoseph E Glass
May 21, 2021·BMJ : British Medical Journal·Megan BureshDarius Rastegar
May 21, 2021·JAMA Network Open·Jennifer McNeelyLeah Hamilton
Jun 26, 2021·JACC. Cardiovascular Interventions·Jaytin Gupta, Hector M Garcia-Garcia
Jul 9, 2021·Human Psychopharmacology·Ty S SchepisSean Esteban McCabe
Jul 28, 2021·The Journal of Alternative and Complementary Medicine : Research on Paradigm, Practice, and Policy·Cheryl HawkDaniel Redwood
Jul 29, 2021·International Journal of Geriatric Psychiatry·Ty S Schepis, Sean Esteban McCabe
Aug 18, 2021·Research in Social & Administrative Pharmacy : RSAP·Julia D Muzzy WilliamsonJustin W Cole
Aug 28, 2021·Journal of Women's Health·Kara R Skelton, Sara E Benjamin-Neelon
Sep 30, 2021·Substance Abuse : Official Publication of the Association for Medical Education and Research in Substance Abuse·Jennifer McNeelyCharles M Cleland
Nov 30, 2021·Journal of Midwifery & Women's Health·Lisa Gesterling, Heather Bradford
Jan 3, 2021·Pediatrics·Scott E HadlandSarah M Bagley
Jan 5, 2022·JAMA Network Open·Sean Esteban McCabePhilip T Veliz
Jan 11, 2022·Annals of Internal Medicine·Jessica L Taylor, Jeffrey H Samet

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.